CSIMarket
 

Miromatrix Medical inc   (NASDAQ: MIRO)

Miromatrix Medical Inc 's

Competitiveness




 

MIRO Sales vs. its Competitors Q3 2023



Comparing the current results to its competitors, Miromatrix Medical Inc reported Revenue decrease in the 3 quarter 2023 year on year by -9.83 %, faster than the overall decrease of Miromatrix Medical Inc 's competitors by -8.65 %, recorded in the same quarter.

List of MIRO Competitors





Revenue Growth Comparisons




Net Income Comparison


Miromatrix Medical inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  MIRO Stock Performance Comparisons



  

Overall company Market Share Q3 2023

Overall company, revenue fell by -9.83 % and company lost market share, to approximately 0 %.




<<  More on MIRO Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Miromatrix Medical inc




Iovance Biotherapeutics inc
Share Performance



+101.95%
This Quarter



Iovance Biotherapeutics inc
Profile

Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients.

More about Iovance Biotherapeutics inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,465.271 mill. $ 285.608 mill. $ -353.860 mill.


Vericel Corporation
Share Performance



-6.29%
Over The Past 5 Days



Vericel Corporation
Profile

Vericel Corporation's business model revolves around the development and commercialization of innovative cellular therapies for the treatment of severe diseases and conditions.

More about Vericel Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,056.307 mill. $ 292.086 mill. $ 21.462 mill.


Soligenix inc
Share Performance



-0.03%
30 Days



Soligenix inc
Profile

Soligenix Inc. is a biopharmaceutical company that focuses on developing and commercializing products to treat rare diseases. Their business model revolves around leveraging their expertise in developing innovative therapies and securing partnerships and collaborations with academic institutions, government agencies, and other companies to accelerate the development process. Soligenix also strategically seeks funding through grants and licensing deals to support their pipeline and growth initiatives.

More about Soligenix inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6.060 mill. $ - mill. $ -9.954 mill.


Organogenesis Holdings Inc
Share Performance



-64.83%
This Year



Organogenesis Holdings Inc
Profile

Organogenesis Holdings Inc is a regenerative medicine company that specializes in the development and commercialization of advanced wound care and surgical biologic products. Their business model revolves around leveraging their expertise in tissue engineering and biotherapeutics to create innovative products aimed at treating various chronic and acute conditions. Through strategic partnerships, they distribute their products globally to healthcare professionals and patients in need, focusing on improving patient outcomes and quality of life.

More about Organogenesis Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 208.309 mill. $ 514.704 mill. $ -9.708 mill.


3m Company
Share Performance



+10.35%
One Year



3m Company
Profile

3M Company operates a diversified business model by offering innovative solutions across multiple segments, including healthcare, safety and industrial, transportation, and consumer goods. The company leverages its extensive portfolio of patents and deep customer relationships to drive product development and market responsiveness, focusing on delivering value across various industries.

More about 3m Company's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 88,933.376 mill. $ 25,180.000 mill. $ 3,012.000 mill.

4 more competitors available

Sign in to see all competitors

Sources: Miromatrix Medical inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Miromatrix Medical inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.